Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: Brazil Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20082
20091
20102
20111
20122
20134
20151
20171
20191
20201
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated4
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
AstraZeneca2
Boehringer Ingelheim2
Pfizer2
Sanofi2
Bayer1
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1
Hospital do Coracao1
Janssen Research & Development, LLC1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction22
Stroke12
Cardiovascular Diseases10
Acute Coronary Syndrome4
Coronary Artery Disease4
Heart Diseases3
Hyperlipidemias3
Angina, Unstable2
Inflammation2
Peripheral Arterial Disease2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.